ST2 Biomarker Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Table of Contents

1 RESEARCH SCOPE

• 1.1 Research Product Definition
• 1.2 Research Segmentation
  • 1.2.1 Product Type
  • 1.2.2 Main product Type of Major Players
• 1.3 Demand Overview
• 1.4 Research Methodology

2 GLOBAL ST2 BIOMARKER INDUSTRY

• 2.1 Summary about ST2 Biomarker Industry
• 2.2 ST2 Biomarker Market Trends
  • 2.2.1 ST2 Biomarker Production & Consumption Trends
  • 2.2.2 ST2 Biomarker Demand Structure Trends
• 2.3 ST2 Biomarker Cost & Price

3 MARKET DYNAMICS

• 3.1 Manufacturing & Purchasing Behavior in 2020
• 3.2 Market Development under the Impact of COVID-19
  • 3.2.1 Drivers
  • 3.2.2 Restraints
  • 3.2.3 Opportunity
  • 3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

• 4.1 Region Segmentation (2017 to 2021f)
  • 4.1.1 North America (U.S., Canada and Mexico)
  • 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  • 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  • 4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  • 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
• 4.2 Product Type Segmentation (2017 to 2021f)
  • 4.2.1 ELISA Based ST2 Biomarker
  • 4.2.2 Immunochromatography Based ST2 Biomarker
• 4.3 Consumption Segmentation (2017 to 2021f)
  • 4.3.1 Hospitals
  • 4.3.2 Diagnostic Centres
  • 4.3.3 Ambulatory Surgical Centres
  • 4.3.4 Others

5 NORTH AMERICA MARKET SEGMENT

• 5.1 Region Segmentation (2017 to 2021f)
  • 5.1.1 U.S.
  • 5.1.2 Canada
  • 5.1.3 Mexico
• 5.2 Product Type Segmentation (2017 to 2021f)
  • 5.2.1 ELISA Based ST2 Biomarker
  • 5.2.2 Immunochromatography Based ST2 Biomarker
• 5.3 Consumption Segmentation (2017 to 2021f)
  • 5.3.1 Hospitals
  • 5.3.2 Diagnostic Centres
  • 5.3.3 Ambulatory Surgical Centres
  • 5.3.4 Others
• 5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

• 6.1 Region Segmentation (2017 to 2021f)
  • 6.1.1 Germany
  • 6.1.2 UK
  • 6.1.3 France
  • 6.1.4 Italy
  • 6.1.5 Rest of Europe
• 6.2 Product Type Segmentation (2017 to 2021f)
  • 6.2.1 ELISA Based ST2 Biomarker
  • 6.2.2 Immunochromatography Based ST2 Biomarker
• 6.3 Consumption Segmentation (2017 to 2021f)
  • 6.3.1 Hospitals
  • 6.3.2 Diagnostic Centres
  • 6.3.3 Ambulatory Surgical Centres
  • 6.3.4 Others
• 6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

• 7.1 Region Segmentation (2017 to 2021f)
  • 7.1.1 China
  • 7.1.2 India
  • 7.1.3 Japan
  • 7.1.4 South Korea
  • 7.1.5 Southeast Asia
  • 7.1.6 Australia
  • 7.1.7 Rest of Asia Pacific
• 7.2 Product Type Segmentation (2017 to 2021f)
  • 7.2.1 ELISA Based ST2 Biomarker
  • 7.2.2 Immunochromatography Based ST2 Biomarker
• 7.3 Consumption Segmentation (2017 to 2021f)
  • 7.3.1 Hospitals
  • 7.3.2 Diagnostic Centres
  • 7.3.3 Ambulatory Surgical Centres
  • 7.3.4 Others
• 7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

• 8.1 Region Segmentation (2017 to 2021f)
  • 8.1.1 Brazil
  • 8.1.2 Argentina
  • 8.1.3 Rest of Latin America
• 8.2 Product Type Segmentation (2017 to 2021f)
  • 8.2.1 ELISA Based ST2 Biomarker
  • 8.2.2 Immunochromatography Based ST2 Biomarker
• 8.3 Consumption Segmentation (2017 to 2021f)
  • 8.3.1 Hospitals
  • 8.3.2 Diagnostic Centres
  • 8.3.3 Ambulatory Surgical Centres
  • 8.3.4 Others
• 8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

• 9.1 Region Segmentation (2017 to 2021f)
  • 9.1.1 GCC
  • 9.1.2 North Africa
  • 9.1.3 South Africa
  • 9.1.4 Rest of Middle East and Africa
• 9.2 Product Type Segmentation (2017 to 2021f)
  • 9.2.1 ELISA Based ST2 Biomarker
  • 9.2.2 Immunochromatography Based ST2 Biomarker
• 9.3 Consumption Segmentation (2017 to 2021f)
  • 9.3.1 Hospitals
  • 9.3.2 Diagnostic Centres
  • 9.3.3 Ambulatory Surgical Centres
  • 9.3.4 Others
• 9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

• 10.1 Brief Introduction of Major Players
  • 10.1.1 Thermo Fisher Scientific
  • 10.1.2 BD
  • 10.1.3 Roche
  • 10.1.4 Abbott
  • 10.1.5 Siemens
  • 10.1.6 Bio-Rad
  • 10.1.7 BioMerieux
• 10.2 ST2 Biomarker Sales Date of Major Players (2017-2020e)
  • 10.2.1 Thermo Fisher Scientific
  • 10.2.2 BD
  • 10.2.3 Roche
  • 10.2.4 Abbott
  • 10.2.5 Siemens
  • 10.2.6 Bio-Rad
  • 10.2.7 BioMerieux
• 10.3 Market Distribution of Major Players
• 10.4 Global Competition Segmentation

11 MARKET FORECAST

• 11.1 Forecast by Region
• 11.2 Forecast by Demand
• 11.3 Environment Forecast
  • 11.3.1 Impact of COVID-19
  • 11.3.2 Geopolitics Overview
  • 11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

List of Table

1.Table ST2 Biomarker Product Type Overview

2.Table ST2 Biomarker Product Type Market Share List

3.Table ST2 Biomarker Product Type of Major Players

4.Table Brief Introduction of Thermo Fisher Scientific

5.Table Brief Introduction of BD

6.Table Brief Introduction of Roche

7.Table Brief Introduction of Abbott

8.Table Brief Introduction of Siemens

9.Table Brief Introduction of Bio-Rad

10.Table Brief Introduction of BioMerieux

11.Table Products & Services of Thermo Fisher Scientific

12.Table Products & Services of BD

13.Table Products & Services of Roche

14.Table Products & Services of Abbott

15.Table Products & Services of Siemens

16.Table Products & Services of Bio-Rad

17.Table Products & Services of BioMerieux

18.Table Market Distribution of Major Players

19.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

20.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

21.Table Global ST2 Biomarker Market Forecast (Million USD) by Region 2021f-2026f

22.Table Global ST2 Biomarker Market Forecast (Million USD) Share by Region 2021f-2026f

23.Table Global ST2 Biomarker Market Forecast (Million USD) by Demand 2021f-2026f

24.Table Global ST2 Biomarker Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure

1.Figure Global ST2 Biomarker Market Size under the Impact of COVID-19, 2017-2021f (USD Million)

2.Figure Global ST2 Biomarker Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)

3.Figure Global ST2 Biomarker Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)

4.Figure Global ST2 Biomarker Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)

5.Figure Global ST2 Biomarker Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)

6.Figure Global ST2 Biomarker Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)

7.Figure Global ST2 Biomarker Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)

8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

13.Figure ELISA Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

14.Figure Immunochromatography Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

15.Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

16.Figure Diagnostic Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

17.Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

22.Figure ELISA Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

23.Figure Immunochromatography Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

24.Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

25.Figure Diagnostic Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

26.Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

33.Figure ELISA Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

34.Figure Immunochromatography Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

35.Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

36.Figure Diagnostic Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

37.Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

46.Figure ELISA Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

47.Figure Immunochromatography Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

48.Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

49.Figure Diagnostic Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

50.Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

55.Figure ELISA Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

56.Figure Immunochromatography Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

57.Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

58.Figure Diagnostic Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

59.Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

65.Figure ELISA Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

66.Figure Immunochromatography Based ST2 Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

67.Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

68.Figure Diagnostic Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

69.Figure Ambulatory Surgical Centres Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

71.Figure ST2 Biomarker Sales Revenue (Million USD) of Thermo Fisher Scientific 2017-2020e

72.Figure ST2 Biomarker Sales Revenue (Million USD) of BD 2017-2020e

73.Figure ST2 Biomarker Sales Revenue (Million USD) of Roche 2017-20